User Menu
  • Log in
  • Consolidated Guidelines
  • Operational Handbooks
  • Training Catalogue
  • Research and Innovation
  • Quick Search
  • Recommendations
Drug dosage finder
User Menu
  • Log in
TB KaSPar Feedback

Breadcrumb

  • Home
  • Module 4: treatment and care

testing1

Profile picture for user falzond@who.int
Submitted by FALZON, Dennis on Wed, 02/17/2021 - 10:42
  • Read more about testing1

testing2

Profile picture for user falzond@who.int
Submitted by FALZON, Dennis on Wed, 02/17/2021 - 10:40
  • Read more about testing2

testing

Profile picture for user falzond@who.int
Submitted by FALZON, Dennis on Wed, 02/17/2021 - 10:38
  • Read more about testing

testing-3

Profile picture for user falzond@who.int
Submitted by FALZON, Dennis on Wed, 02/17/2021 - 10:07
  • Read more about testing-3

test2

Profile picture for user falzond@who.int
Submitted by FALZON, Dennis on Wed, 02/17/2021 - 08:59
  • Read more about test2

test

Profile picture for user falzond@who.int
Submitted by FALZON, Dennis on Thu, 02/04/2021 - 12:09
  • Read more about test

Module 1: TB laboratory biosafety

Image
modified handbook biosafety

WHO consolidated guidelines on tuberculosis: Module 4: Treatment Drug-resistant tuberculosis treatment ONLINE ANNEXE

WHO_UCN_TB_2020_1_9

  • Read more about WHO_UCN_TB_2020_1_9

Systematic LTBI testing and treatment may be considered for prisoners, health workers,
immigrants from countries with a high TB burden, homeless people and people who use drugs.

WHO_UCN_TB_2020_1_8

  • Read more about WHO_UCN_TB_2020_1_8

People who are initiating anti-TNF treatment, or receiving dialysis, or preparing for an organ
or haematological transplant, or who have silicosis should be systematically tested and treated
for LTBI.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 23
  • Page 24
  • Page 25
  • Page 26
  • Current page 27
  • Page 28
  • Page 29
  • Page 30
  • Page 31
  • …
  • Next page Next ›
  • Last page Last »
who logo
  • Department for HIV, Tuberculosis, Hepatitis & Sexually Transmitted Infections (HTH)
  • Privacy Legal Notice
  • Feedback
  • © 2026 WHO
We value your privacy

We use cookies on our website to give you the most relevant experience by remembering your preferences during repeat visits. By clicking “Accept”, you consent to the use of all the cookies.

To learn more, please read our privacy policy.